Vascular Biogenics Overview

Vascular Biogenics Gross Profit

Gross Profit analysis for VBLT.

Quarterly Gross Profit

$2000.00

As of Jun 30, 2024

Annual Gross Profit (TTM)

$161000.00

↓ 73.48% YoY

Trailing 12 months ending Jun 30, 2024

Average Gross Profit (Comparison Companies)

Gross Profit History

Gross Profit Comparison

Annual Gross Profit Growth Rate (%)

Annual Gross Profit Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin